Medgenics Inc (MDGN)

5.76
0.04 0.69
AMEX : Health Care
Prev Close 5.80
Open 5.78
Day Low/High 5.68 / 5.87
52 Wk Low/High 3.09 / 10.25
Volume 62.38K
Avg Volume 150.80K
Exchange AMEX
Shares Outstanding 37.08M
Market Cap 212.09M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

RSI Alert: Medgenics (MDGN) Now Oversold

RSI Alert: Medgenics (MDGN) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

MDGN: Insiders vs. Shorts

MDGN: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 12/15/2015 settlement date, and Medgenics Inc is one of the most shorted stocks of the Russell 3000, based on 13.54 "days to cover" versus the median component at 5.46. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Medgenics Announces Key Appointments

Medgenics Announces Key Appointments

MDGN: Insiders vs. Shorts

MDGN: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 09/15/2015 settlement date, and Medgenics Inc is one of the most shorted stocks of the Russell 3000, based on 9.38 "days to cover" versus the median component at 6.87. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector

Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector

The shares of Spark Therapeutics are surging after the company announced that its lead gene therapy product candidate had met its primary endpoint in a Phase 3 trial.

Short Interest Increases 15% For MDGN

Short Interest Increases 15% For MDGN

The most recent short interest data has been released by the NASDAQ for the 08/14/2015 settlement date, which shows a 270,220 share increase in total short interest for Medgenics Inc , to 2,060,407, an increase of 15.09% since 07/31/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Short Interest Expands By 61.4% For MDGN

Short Interest Expands By 61.4% For MDGN

The most recent short interest data has been released by the NASDAQ for the 07/15/2015 settlement date, which shows a 498,506 share increase in total short interest for Medgenics Inc , to 1,309,814, an increase of 61.44% since 06/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Medgenics Becomes Oversold (MDGN)

Medgenics Becomes Oversold (MDGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.